Cargando…

Community-Level Pharmaceutical Interventions to Reduce the Risks of Polypharmacy in the Elderly: Overview of Systematic Reviews and Economic Evaluations

Background: Patients over 65 years of age taking multiple medications face several risks, and pharmaceutical interventions can be useful to improve quality of care and reduce those risks. However, there is still no consensus on the effectiveness of these interventions aimed at promoting changes in c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soler, Orenzio, Barreto, Jorge Otávio Maia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454558/ https://www.ncbi.nlm.nih.gov/pubmed/31001117 http://dx.doi.org/10.3389/fphar.2019.00302

Ejemplares similares

Risk prediction model of polypharmacy for community-dwelling elderly patients: An assessment tool for early detection
por: Tang, Qi, et al.
Publicado: (2022)

Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region
por: Burato, Sofia, et al.
Publicado: (2021)

Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020)
por: Cebrino, Jesús, et al.
Publicado: (2023)

Polypharmacy Management in the Older Adults: A Scoping Review of Available Interventions
por: Kurczewska-Michalak, M., et al.
Publicado: (2021)

Prevalence of Chronic Polypharmacy in Community-Dwelling Elderly People in Poland: Analysis of National Real-World Database Helps to Identify High Risk Group
por: Kardas, Przemysław, et al.
Publicado: (2021)

Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry
por: Owusu-Asante, Mercy, et al.
Publicado: (2023)

A Comprehensive Overview of Polypharmacy in Elderly Patients in Saudi Arabia
por: Alsuwaidan, Aseel, et al.
Publicado: (2019)

Predictors of Polypharmacy Among Elderly Patients in China: The Role of Decision Involvement, Depression, and Taking Chinese Medicine Behavior
por: Chen, Chaoyi, et al.
Publicado: (2021)

Prevalence of Polypharmacy and Potentially Inappropriate Medications Use in Elderly Chinese Patients: A Systematic Review and Meta-Analysis
por: Tian, Fangyuan, et al.
Publicado: (2022)

Optimizing polypharmacy management in the elderly: a comprehensive European benchmarking survey and the development of an innovative online benchmarking application
por: Kardas, Przemysław, et al.
Publicado: (2023)

Strategies Implemented by Public Institutions to Approach the Judicialization of Health Care in Brazil: A Systematic Scoping Review
por: Yamauti, Sueli Miyuki, et al.
Publicado: (2020)

Polypharmacy and Nutraceuticals in Veterans: Pros and Cons
por: Sciarra, Tommaso, et al.
Publicado: (2019)

An Overview of the Evidence and Mechanism of Drug–Herb Interactions Between Propolis and Pharmaceutical Drugs
por: Hossain, Sanowar, et al.
Publicado: (2022)

Polypharmacy in the elderly
por: Golchin, Negar, et al.
Publicado: (2015)

Polypharmacy Cut-Off for Gait and Cognitive Impairments
por: Langeard, Antoine, et al.
Publicado: (2016)

Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
por: Gasperetti, Tracy, et al.
Publicado: (2021)

Associated adverse health outcomes of polypharmacy and potentially inappropriate medications in community-dwelling older adults with diabetes
por: Lu, Lvliang, et al.
Publicado: (2023)

High Prevalence of Multimorbidity and Polypharmacy in Elderly Patients With Chronic Pain Receiving Home Care are Associated With Multiple Medication-Related Problems
por: Schneider, Juliana, et al.
Publicado: (2021)

Knowledge Translation for Improving the Care of Deinstitutionalized People With Severe Mental Illness in Health Policy
por: Fulone, Izabela, et al.
Publicado: (2020)

Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010–2019
por: Cho, Ho Jin, et al.
Publicado: (2022)

Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
por: Gasperetti, Tracy, et al.
Publicado: (2021)

Barriers and facilitators to maintaining a high level of polypharmacy adherence in people living with HIV: A scoping review
por: He, Jiamin, et al.
Publicado: (2023)

Polypharmacy among the Elderly
por: Hosseini, Seyed Reza, et al.
Publicado: (2018)

Impact of the expert consensus on polypharmacy and potentially inappropriate medication use in elderly lung cancer outpatients with multimorbidity: An interrupted time series analysis, 2016–2021
por: Tian, Fangyuan, et al.
Publicado: (2022)

Intervention to Improve Appropriate Prescribing and Reduce Polypharmacy in Elderly Patients Admitted to an Internal Medicine Unit
por: Urfer, Milena, et al.
Publicado: (2016)

An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study
por: Zhang, Naiqi, et al.
Publicado: (2020)

Does Having a Usual Primary Care Provider Reduce Polypharmacy Behaviors of Patients With Chronic Disease? A Retrospective Study in Hubei Province, China
por: Wang, Jia, et al.
Publicado: (2022)

Is Excessive Polypharmacy a Transient or Persistent Phenomenon? A Nationwide Cohort Study in Taiwan
por: Wang, Yi-Jen, et al.
Publicado: (2018)

Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation
por: Takamoto, Kojiro, et al.
Publicado: (2021)

Geriatrician-led multidisciplinary team management improving polypharmacy among older inpatients in China
por: Song, Yi, et al.
Publicado: (2023)

Quantitative Systems Pharmacology can reduce attrition and improve productivity in pharmaceutical research and development
por: Leil, Tarek A., et al.
Publicado: (2014)

An overview of prevalence, determinants and health outcomes of polypharmacy
por: Khezrian, Mina, et al.
Publicado: (2020)

Editorial: New Horizons in Health-Promoting: From Methods to Implementation Science
por: Barberato-Filho, Silvio, et al.
Publicado: (2022)

An Overview of the Impact of Pharmaceuticals on Aquatic Microbial Communities
por: Pinto, Isabel, et al.
Publicado: (2022)

Prescription Rates, Polypharmacy and Prescriber Variability in Swiss General Practice—A Cross-Sectional Database Study
por: Rachamin, Yael, et al.
Publicado: (2022)

Prevalence and global trends of polypharmacy in patients with chronic kidney disease: A systematic review and meta-analysis
por: Naseralallah, Lina, et al.
Publicado: (2023)

Diseases Linked to Polypharmacy in Elderly Patients
por: Vrettos, Ioannis, et al.
Publicado: (2017)

Editorial: Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals
por: Ramadan, Nehal M., et al.
Publicado: (2023)

Evaluation of the effectiveness and efficiency of the East African community joint assessment procedure by pharmaceutical companies: Opportunities for improvement
por: Ngum, Nancy, et al.
Publicado: (2022)

Psychotropic Polypharmacy in Adults 55 Years or Older: A Risk for Impaired Global Cognition, Executive Function, and Mobility
por: Loggia, Gilles, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h66l1sluehti35r8jfng9uvbbt